Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Serina Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 33 | 32 | −1 |
| Shares | 4.78M | 4.75M | −33.6K (−0.7%) |
| Value | $2.75M | $2.67M | −$87.0K (−3.2%) |
New holders (2)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 20,590 | $12.0K | 0.00% |
| Trust Co of Vermont | 100 | $0 | 0.00% |
Sold out (3)
Institutions that held Serina Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Two Sigma Securities, LLC | 10,875 | $6.00K |
| Royal Bank of Canada | 45 | $0 |
| CoreCap Advisors, LLC | 10 | $0 |